Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
WO2009105234A2
Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein
KR20100121601A
Therapeutic regimens for the treatment of immunoinflammatory disorders
EP2203174A1
Therapeutic regimens for the treatment of immunoinflammatory disorders
CA2694987A1
Combinations for the treatment of b-cell proliferative disorders
BRPI0813516A2
Treatment of proliferative b-cell disorders
WO2009002507A1
Compositions and methods for treating medical conditions
WO2008133884A2
Methods and compositions for the treatment of neurodegenerative disorders
AU2008234141A1
Methods for treating neovascular ocular diseases
WO2008118426A1
Split dose corticosteroid therapy
WO2008118423A1
Compositions and methods for treating medical conditions
AU2008201319A1
Combinations for the treatment of immunoinflammatory disorders
AU2008201073A1
Combinations for the treatment of inflammatory disorders
WO2008085927A2
Methods, compositions, and kits for the treatment of pain
EP2063867A2
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
TW200824678A
Methods and compositions for the treatment of neurodegenerative disorders
TW200814968A
Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein levels
WO2007139753A2
Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
KR20080112270A
Compositions and methods for the treatment of immunoinflammatory disorders
TW200744611A
Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
